Steven Cohen Likes These Fund Managers

Reuters is publishing parts of Steve Cohen’s sworn deposition testimony in Fairfax Financial case. Here is the part where Steven Cohen reveals the names of fund managers he keeps in touch:


BOWE: Okay. Well, back in 2002 through 2006, your group, at that point in time did you talk to other funds?
COHEN: “I talked to — I’ve always talked to very few funds.”
BOWE: Which funds then — which funds did you typically talk to?
COHEN: “I might talk to my friend, Jay Goldman, he’s someone I might talk to. I might talk to –
BOWE: What fund is he at?
COHEN: “Jay Goldman Associates. Who else do I talk to? I might talk to — I mean, I might — it’s not something I did a lot. I mean, very few funds. I talked to a friend of mine, Ken Ginsberg, who is an old friend from high school. And then very rarely would I talk to somebody in other firms, but it certainly happened.”
BOWE: Okay. Since it happened so rarely, can you tell me what funds?
COHEN: “Well, I mean, Adam Sender, I mean there were times in my career where I’ve spoken to him.”
BOWE: Okay, what other funds?
COHEN: “You know, there might have been a few communications with Dan Loeb in my career.” Certainly Kingdon, I can remember talking to somebody over there.”

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!